 | • レポートコード：MRC2-11QY11620 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は皮膚壊死治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制剤、コルチコステロイド）市場規模、用途別（病院、クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚壊死治療の競争状況、市場シェア ・世界の皮膚壊死治療市場：種類別市場規模 2015年-2020年（免疫抑制剤、コルチコステロイド） ・世界の皮膚壊死治療市場：種類別市場規模予測 2021年-2026年（免疫抑制剤、コルチコステロイド） ・世界の皮膚壊死治療市場：用途別市場規模 2015年-2020年（病院、クリニック、外来手術センター） ・世界の皮膚壊死治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来手術センター） ・北米の皮膚壊死治療市場分析：米国、カナダ ・ヨーロッパの皮膚壊死治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚壊死治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚壊死治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚壊死治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、Boston Therapeutics、Amgen、AstraZeneca、Glaxo Smithkline Pharmaceuticals、Systopic Laboratories、Sun Pharmaceuticals、RPG Life Sciences、Zydus Cadila ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough history is mandatory including recent reavel, drugs, underlying illnesses and recent surgical procedures. Blood tests that are often helpful are creatinine phosphokinase, blood cultures, antinuclear antibodies, rheumatoid factor, antinuclear cytoplasmic antibodies, hypercoagulability screen, creatinine, complete blood count and human immunodeficiency virus test. Other procedures such as computerized axial tomography and magnetic resonance imaging also helps to determine the extent of disease.
The dermal necrosis market is expected to witness growth as it is a highly undiscovered area. Moreover, Coumadin necrosis, Heparin necrosis and Calciphylaxis are diseases for which no therapies are proven beneficial. This offers an area of unmet needs where market players can develop a molecule and form a strong position in the dermal necrosis treatment market. TISSEEL Kit, from Baxter is an example of device which is used for management of skin necrosis and mucosal ulcers. The device is a two-component fibrin sealant offers highly concentrated human fibrinogen to seal tissue and stop diffuse bleeding.
Market Analysis and Insights: Global Dermal Necrosis Treatment Market
The global Dermal Necrosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Dermal Necrosis Treatment Scope and Market Size
Dermal Necrosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermal Necrosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Baxter
Boston Therapeutics
Amgen
AstraZeneca
Glaxo Smithkline Pharmaceuticals
Systopic Laboratories
Sun Pharmaceuticals
RPG Life Sciences
Zydus Cadila
Market segment by Type, the product can be split into
Immunosuppressive Agents
Corticosteroids
Market segment by Application, split into
Hospital
Clinics
Ambulatory Surgery Center
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dermal Necrosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Dermal Necrosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunosuppressive Agents
1.4.3 Corticosteroids
1.5 Market by Application
1.5.1 Global Dermal Necrosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Ambulatory Surgery Center
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Dermal Necrosis Treatment Market Perspective (2015-2026)
2.2 Global Dermal Necrosis Treatment Growth Trends by Regions
2.2.1 Dermal Necrosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dermal Necrosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Dermal Necrosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dermal Necrosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Dermal Necrosis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Dermal Necrosis Treatment Players by Market Size
3.1.1 Global Top Dermal Necrosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Dermal Necrosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Dermal Necrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dermal Necrosis Treatment Market Concentration Ratio
3.2.1 Global Dermal Necrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dermal Necrosis Treatment Revenue in 2019
3.3 Dermal Necrosis Treatment Key Players Head office and Area Served
3.4 Key Players Dermal Necrosis Treatment Product Solution and Service
3.5 Date of Enter into Dermal Necrosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dermal Necrosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Dermal Necrosis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Dermal Necrosis Treatment Market Size by Application (2015-2020)
5.2 Global Dermal Necrosis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Dermal Necrosis Treatment Market Size (2015-2020)
6.2 Dermal Necrosis Treatment Key Players in North America (2019-2020)
6.3 North America Dermal Necrosis Treatment Market Size by Type (2015-2020)
6.4 North America Dermal Necrosis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Dermal Necrosis Treatment Market Size (2015-2020)
7.2 Dermal Necrosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Dermal Necrosis Treatment Market Size by Type (2015-2020)
7.4 Europe Dermal Necrosis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Dermal Necrosis Treatment Market Size (2015-2020)
8.2 Dermal Necrosis Treatment Key Players in China (2019-2020)
8.3 China Dermal Necrosis Treatment Market Size by Type (2015-2020)
8.4 China Dermal Necrosis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Dermal Necrosis Treatment Market Size (2015-2020)
9.2 Dermal Necrosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Dermal Necrosis Treatment Market Size by Type (2015-2020)
9.4 Japan Dermal Necrosis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Dermal Necrosis Treatment Market Size (2015-2020)
10.2 Dermal Necrosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dermal Necrosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Dermal Necrosis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Dermal Necrosis Treatment Market Size (2015-2020)
11.2 Dermal Necrosis Treatment Key Players in India (2019-2020)
11.3 India Dermal Necrosis Treatment Market Size by Type (2015-2020)
11.4 India Dermal Necrosis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Dermal Necrosis Treatment Market Size (2015-2020)
12.2 Dermal Necrosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Dermal Necrosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Dermal Necrosis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview
13.1.3 Baxter Dermal Necrosis Treatment Introduction
13.1.4 Baxter Revenue in Dermal Necrosis Treatment Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 Boston Therapeutics
13.2.1 Boston Therapeutics Company Details
13.2.2 Boston Therapeutics Business Overview
13.2.3 Boston Therapeutics Dermal Necrosis Treatment Introduction
13.2.4 Boston Therapeutics Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.2.5 Boston Therapeutics Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Dermal Necrosis Treatment Introduction
13.3.4 Amgen Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Dermal Necrosis Treatment Introduction
13.4.4 AstraZeneca Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Glaxo Smithkline Pharmaceuticals
13.5.1 Glaxo Smithkline Pharmaceuticals Company Details
13.5.2 Glaxo Smithkline Pharmaceuticals Business Overview
13.5.3 Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Introduction
13.5.4 Glaxo Smithkline Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.5.5 Glaxo Smithkline Pharmaceuticals Recent Development
13.6 Systopic Laboratories
13.6.1 Systopic Laboratories Company Details
13.6.2 Systopic Laboratories Business Overview
13.6.3 Systopic Laboratories Dermal Necrosis Treatment Introduction
13.6.4 Systopic Laboratories Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.6.5 Systopic Laboratories Recent Development
13.7 Sun Pharmaceuticals
13.7.1 Sun Pharmaceuticals Company Details
13.7.2 Sun Pharmaceuticals Business Overview
13.7.3 Sun Pharmaceuticals Dermal Necrosis Treatment Introduction
13.7.4 Sun Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.7.5 Sun Pharmaceuticals Recent Development
13.8 RPG Life Sciences
13.8.1 RPG Life Sciences Company Details
13.8.2 RPG Life Sciences Business Overview
13.8.3 RPG Life Sciences Dermal Necrosis Treatment Introduction
13.8.4 RPG Life Sciences Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.8.5 RPG Life Sciences Recent Development
13.9 Zydus Cadila
13.9.1 Zydus Cadila Company Details
13.9.2 Zydus Cadila Business Overview
13.9.3 Zydus Cadila Dermal Necrosis Treatment Introduction
13.9.4 Zydus Cadila Revenue in Dermal Necrosis Treatment Business (2015-2020)
13.9.5 Zydus Cadila Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Dermal Necrosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Dermal Necrosis Treatment Revenue
Table 3. Ranking of Global Top Dermal Necrosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dermal Necrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunosuppressive Agents
Table 6. Key Players of Corticosteroids
Table 7. Global Dermal Necrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Dermal Necrosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Dermal Necrosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Dermal Necrosis Treatment Market Share by Regions (2015-2020)
Table 11. Global Dermal Necrosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Dermal Necrosis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Dermal Necrosis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Dermal Necrosis Treatment Players
Table 18. Global Dermal Necrosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Dermal Necrosis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Dermal Necrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Necrosis Treatment as of 2019)
Table 21. Global Dermal Necrosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Dermal Necrosis Treatment Product Solution and Service
Table 24. Date of Enter into Dermal Necrosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Dermal Necrosis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Dermal Necrosis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Dermal Necrosis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Dermal Necrosis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 34. North America Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 36. North America Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 40. Europe Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 42. Europe Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 46. China Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 48. China Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 52. Japan Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 54. Japan Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 64. India Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 66. India Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Dermal Necrosis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Dermal Necrosis Treatment Market Share (2019-2020)
Table 70. Central & South America Dermal Necrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Dermal Necrosis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Dermal Necrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Dermal Necrosis Treatment Market Share by Application (2015-2020)
Table 74. Baxter Company Details
Table 75. Baxter Business Overview
Table 76. Baxter Product
Table 77. Baxter Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 78. Baxter Recent Development
Table 79. Boston Therapeutics Company Details
Table 80. Boston Therapeutics Business Overview
Table 81. Boston Therapeutics Product
Table 82. Boston Therapeutics Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 83. Boston Therapeutics Recent Development
Table 84. Amgen Company Details
Table 85. Amgen Business Overview
Table 86. Amgen Product
Table 87. Amgen Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 88. Amgen Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Product
Table 92. AstraZeneca Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 93. AstraZeneca Recent Development
Table 94. Glaxo Smithkline Pharmaceuticals Company Details
Table 95. Glaxo Smithkline Pharmaceuticals Business Overview
Table 96. Glaxo Smithkline Pharmaceuticals Product
Table 97. Glaxo Smithkline Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 98. Glaxo Smithkline Pharmaceuticals Recent Development
Table 99. Systopic Laboratories Company Details
Table 100. Systopic Laboratories Business Overview
Table 101. Systopic Laboratories Product
Table 102. Systopic Laboratories Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 103. Systopic Laboratories Recent Development
Table 104. Sun Pharmaceuticals Company Details
Table 105. Sun Pharmaceuticals Business Overview
Table 106. Sun Pharmaceuticals Product
Table 107. Sun Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 108. Sun Pharmaceuticals Recent Development
Table 109. RPG Life Sciences Business Overview
Table 110. RPG Life Sciences Product
Table 111. RPG Life Sciences Company Details
Table 112. RPG Life Sciences Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 113. RPG Life Sciences Recent Development
Table 114. Zydus Cadila Company Details
Table 115. Zydus Cadila Business Overview
Table 116. Zydus Cadila Product
Table 117. Zydus Cadila Revenue in Dermal Necrosis Treatment Business (2015-2020) (Million US$)
Table 118. Zydus Cadila Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermal Necrosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunosuppressive Agents Features
Figure 3. Corticosteroids Features
Figure 4. Global Dermal Necrosis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgery Center Case Studies
Figure 8. Dermal Necrosis Treatment Report Years Considered
Figure 9. Global Dermal Necrosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Dermal Necrosis Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Dermal Necrosis Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Dermal Necrosis Treatment Market Share by Players in 2019
Figure 14. Global Top Dermal Necrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Necrosis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Dermal Necrosis Treatment Revenue in 2019
Figure 16. North America Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Dermal Necrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
無血管性壊死（AVN）の世界市場（～2026年） Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby jo…- 皮膚用接着剤の世界市場（～2026年） A dermal adhesive (or skin glue) is a glue used to close wounds in the skin, as an alternative to sutures, staples or clips. Glued closure produces less scarring and is less prone to infection than sutured or stapled closure. There is also no residual closure to remove, so follow-up visits for remov…
- 腫瘍壊死因子α阻害剤の世界市場（～2026年） The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…
- 腫瘍壊死因子阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Market The global Tumor Necrosis Factor Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Scope and Market…
- 腫瘍壊死因子阻害薬の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Drug Market The global Tumor Necrosis Factor Inhibitors Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Drug S…